Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[11C]Diprenorphine PET in Anorexia Nervosa
NCT02524301Completed
- Sponsor
- CHU Saint-Etienne
- Start
- Sep 2009
- Primary completion
- Jul 2016
- Countries
- 1
01
Overview
Open-label trial (3 arms), sponsored by CHU Saint-Etienne. Primary endpoint: [11C]diprenorphine binding potential at week 2. Started Sep 2009; status: completed.
Beyond the preview
Go deeper on NCT02524301.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02524301.